Objective: Although several pharmacological agents have emerged as potential adjunctive therapies to a gluten-free diet for coeliac disease, there is currently no widely accepted measure of disease activity used in clinical trials. We conducted a systematic review of coeliac disease activity indices to evaluate their operating properties and potential as outcome measures in registration trials.


Outcome Assessment, Biomarker, COELIAC DISEASE, GLUTEN SENSITIVE ENTEROPATHY, Celiac Disease, Clinical Trials, Pathology, Endoscopy, Gastrointestinal, Therapy, Diagnosis

Read More